Agentix (AGTX) Accumulated Expenses (2014 - 2026)
Agentix's (AGTX) quarterly Accumulated Expenses came in at $143889.0 in Q1 2026, up 139.03% YoY from $60197.0 in Q1 2025, and up 16.5% on a QoQ basis from $123510.0 in Q4 2025.
Agentix (AGTX) Accumulated Expenses (2014 - 2026) Analysis & Trends
Agentix (AGTX) has 13 years of Accumulated Expenses data on file, last reported at $143889.0 in Q1 2026.
- Quarterly Accumulated Expenses rose 139.03% year-over-year to $143889.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $143889.0 (up 139.03% YoY) and the FY2026 annual result came in at $143889.0, up 139.03% from the prior year.
- Accumulated Expenses advanced to $143889.0 in Q1 2026, from $123510.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $143889.0 in Q1 2026 to a low of $100.0 in Q1 2022.
- A 5-year average of $42486.7 and a median of $23815.0 in 2024 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Accumulated Expenses changed 0.0% — and 2023, when it soared 22121.0%.
- Tracing AGTX's Accumulated Expenses over 5 years: stood at $100.0 in 2022, then soared by 22121.0% to $22221.0 in 2023, then jumped by 118.24% to $48495.0 in 2024, then soared by 154.69% to $123510.0 in 2025, then advanced by 16.5% to $143889.0 in 2026.
- The last three Accumulated Expenses figures came in at $143889.0 (Q1 2026), $123510.0 (Q4 2025), and $109703.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Agentix | 801,339.00 | 801,301.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 165,511.00 |
| Mar 31, 2026 | 143,889.00 |
| Dec 31, 2025 | 123,510.00 |
| Sep 30, 2025 | 109,703.00 |
| Jun 30, 2025 | 84,366.00 |
| Mar 31, 2025 | 60,197.00 |
| Dec 31, 2024 | 48,495.00 |
| Sep 30, 2024 | 38,168.00 |
| Jun 30, 2024 | 35,252.00 |
| Mar 31, 2024 | 23,815.00 |
| Dec 31, 2023 | 22,221.00 |
| Sep 30, 2023 | 9,156.00 |
| Jun 30, 2023 | 13,992.00 |
| Mar 31, 2023 | 9,110.00 |
| Dec 31, 2022 | 100.00 |
| Sep 30, 2022 | 100.00 |
| Jun 30, 2022 | 100.00 |
| Feb 28, 2022 | 100.00 |
| Nov 30, 2021 | 100.00 |
| Aug 31, 2021 | 100.00 |